Management of type 2 diabetes with a treat-to-benefit approach improved long-term cardiovascular outcomes under routine care.
Mario Luca MorieriEnrico LongatoBarbara Di CamilloGiovanni SparacinoAngelo AvogaroGian Poalo FadiniPublished in: Cardiovascular diabetology (2022)
Managing patients with T2D according to a "treat-to-benefit" approach based international standards was associated with a lower risk of MACE, heart failure, and mortality. These data provide ex-post validation of the ADA/EASD treatment algorithm.
Keyphrases
- heart failure
- type diabetes
- healthcare
- palliative care
- machine learning
- cardiovascular events
- electronic health record
- cardiovascular disease
- deep learning
- quality improvement
- left ventricular
- big data
- atrial fibrillation
- glycemic control
- pain management
- insulin resistance
- coronary artery disease
- combination therapy
- metabolic syndrome
- data analysis
- weight loss
- replacement therapy
- affordable care act
- smoking cessation